{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:26:06Z","timestamp":1753892766311,"version":"3.41.2"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Increasing reports of manic episodes in patients during acute infection with COVID-19 have been documented since the pandemic began, including individuals without a previous personal or family history of bipolar disorder. As infections and autoimmunity have putative roles in bipolar disorder, we aimed to document the clinical presentations, associated stressors, family aggregation patterns, and brain imaging and electroencephalographic correlates with a series of patients with episodes of mania that emerged shortly after COVID-19 infections.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We obtained all relevant clinical information from 12 patients whose first manic episode started within a month of COVID-19 infection and were treated at Rasool-e-Akram hospital and Iran psychiatric hospital, two tertiary medical centers in Tehran, Iran, in 2021.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients had a mean age of 44. The interval between the onset of symptoms of COVID and mania ranged between 0 and 28\u2009days (mean: 16.25, median: 14\u2009days); it was observed to be shorter in patients with a family history of mood disorders but not in those receiving corticosteroids. Alongside a descriptive overview of our sample, we provide detailed narrative descriptions of two of the cases for illustrative purposes and discuss our observations in the context of other cases reported elsewhere and the state-of-the-art regarding infectious diseases, COVID-19, and bipolar disorder as reported in previous literature.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our case series documents observational and naturalistic evidence from a dozen of cases of mania in the context of acute COVID-19, which, while limited, calls for analytical research of the phenomenon, and points at a family history of bipolar disorder and the use of corticosteroids as factors for particular focus.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2023.1102450","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T06:05:15Z","timestamp":1681193115000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["First-episode mania after COVID-19: A case series in Iran"],"prefix":"10.3389","volume":"14","author":[{"given":"Mahdieh","family":"Saeidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Rezvankhah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Pereira-Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Rafieian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behnam","family":"Shariati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soode Tajik","family":"Esmaeeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maziar","family":"Emamikhah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaveh","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiva","family":"Soraya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Kashaninasab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh Sadat","family":"Mirfazeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jocn.2020.05.017","article-title":"Neurological manifestations and complications of COVID-19: a literature review","volume":"77","author":"Ahmad","year":"2020","journal-title":"J Clin Neurosci"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"110159","DOI":"10.1016\/j.pnpbp.2020.110159","article-title":"The psychiatric and neuropsychiatric repercussions associated with severe infections of COVID-19 and other coronaviruses","volume":"106","author":"de Sousa Moreira","year":"2021","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00406-021-01244-0","article-title":"Neurological and psychiatric presentations associated with COVID-19","volume":"272","author":"He","year":"2022","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11920-021-01237-9","article-title":"Neuropsychiatric complications of COVID-19","volume":"23","author":"Nakamura","year":"2021","journal-title":"Curr Psychiatry Rep"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-86705-8_1","article-title":"Pathophysiology of COVID-19-associated neurotoxicity","volume-title":"Features and Management of Acute and Chronic Neuro-Covid","author":"Cascella","year":"2022"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1176\/appi.neuropsych.20110277","article-title":"COVID-19 infection: a neuropsychiatric perspective","volume":"33","author":"Manolis","year":"2021","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-78050-6","article-title":"Neuropsychiatric manifestations of COVID-19 can be clustered in three distinct symptom categories","volume":"10","author":"Mirfazeli","year":"2020","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S2215-0366(20)30462-4","article-title":"Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA","volume":"8","author":"Taquet","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1056\/NEJMra1906193","article-title":"Bipolar disorder","volume":"383","author":"Carvalho","year":"2020","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/jamapsychiatry.2014.2502","article-title":"Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis","volume":"72","author":"Walker","year":"2015","journal-title":"JAMA Psychiat"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1017\/S2045796021000305","article-title":"Excess mortality and life-years lost in people with bipolar disorder: an 11-year population-based cohort study","volume":"30","author":"Chan","year":"2021","journal-title":"Epidemiol Psychiatr Sci"},{"key":"ref13","first-page":"40","article-title":"Cardiovascular morbidity and mortality in bipolar disorder","volume":"23","author":"Weiner","year":"2011","journal-title":"Ann Clin Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar disorder","volume":"387","author":"Grande","year":"2016","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"113115","DOI":"10.1016\/j.psychres.2020.113115","article-title":"Affective psychosis after COVID-19 infection in a previously healthy patient: a case report","volume":"290","author":"Correa-Palacio","year":"2020","journal-title":"Psychiatry Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1708\/3457.34465","article-title":"Case reports of first psychiatric presentations during CoViD-19 pandemic","volume":"55","author":"Lazzari","year":"2020","journal-title":"Riv Psichiatr"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jad.2020.08.031","article-title":"First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder","volume":"277","author":"Lu","year":"2020","journal-title":"J Affect Disord"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"034","DOI":"10.17352\/apt.000018","article-title":"First manic episode in 14-year-old adolescent during COVID-19 pandemic lockdown measures: a case report","volume":"4","author":"Marchini","year":"2020","journal-title":"Ann Psychiatry Treatment"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e236123","DOI":"10.1136\/bcr-2020-236123","article-title":"Neurotropism of SARS-CoV-2: COVID-19 presenting with an acute manic episode","volume":"13","author":"Mawhinney","year":"2020","journal-title":"BMJ Case Reports CP"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jpsychires.2020.07.042","article-title":"Letter to the editor: new onset psychosis and mania following COVID-19 infection","volume":"130","author":"Noone","year":"2020","journal-title":"J Psychiatr Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jocn.2021.02.012","article-title":"SARS-CoV-2-associated first episode of acute mania with psychotic features","volume":"87","author":"Sen","year":"2021","journal-title":"J Clin Neurosci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1192\/bjo.2021.182","article-title":"Acute mania with psychotic symptom in post COVID-19 patient","volume":"7","author":"Shanmugam","year":"2021","journal-title":"BJPsych Open"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4306\/pi.2016.13.1.18","article-title":"Bipolar disorder: role of inflammation and the development of disease biomarkers","volume":"13","author":"Muneer","year":"2016","journal-title":"Psychiatry Investig"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0022-3956(99)00007-2","article-title":"Immune parameters in rapid cycling bipolar patients before and after lithium treatment","volume":"33","author":"Rapaport","year":"1999","journal-title":"J Psychiatr Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.30834\/KJP.34.1.2021.264","article-title":"A case report of manic episode following SARS-CoV-2 infection","volume":"34","author":"Devasia","year":"2021","journal-title":"Kerala J Psychiatry"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1097\/YCT.0000000000000789","article-title":"A case of delirious mania induced by COVID-19 treated with electroconvulsive therapy","volume":"37","author":"Reinfeld","year":"2021","journal-title":"J. ECT"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"786","DOI":"10.9758\/cpn.2021.19.4.786","article-title":"First Manic Attack During COVID-19 Treatment: A Case Report","volume":"19","author":"Varsak","year":"2021","journal-title":"Clin. Psychopharmacol Neurosci."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1007\/s10072-021-05390-0","article-title":"Could COVID-19 be a trigger for manic attack in an adolescent?","volume":"42","author":"Uzun","year":"2021","journal-title":"Neurol. Sci."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12038-021-00165-3","article-title":"COVID-19 and central nervous system interplay: a big picture beyond clinical manifestation","volume":"46","author":"Chaudhury","year":"2021","journal-title":"J Biosci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"660087","DOI":"10.3389\/fneur.2021.660087","article-title":"Elucidating the neuropathologic mechanisms of SARS-CoV-2 infection","volume":"12","author":"Pacheco-Herrero","year":"2021","journal-title":"Front Neurol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00221-021-06244-z","article-title":"Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients","author":"Veleri","year":"2021","journal-title":"Exp Brain Res"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/jmcb\/mjab044","article-title":"Emerging neurotropic features of SARS-CoV-2","volume":"13","author":"Zhan","year":"2021","journal-title":"J Mol Cell Biol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1177\/10738584211015136","article-title":"Unravelling pathophysiology of neurological and psychiatric complications of COVID-19 using brain organoids","author":"Ng","year":"2021","journal-title":"Neuroscientist"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e0116696","DOI":"10.1371\/journal.pone.0116696","article-title":"Infection and inflammation in schizophrenia and bipolar disorder: a genome wide study for interactions with genetic variation","volume":"10","author":"Avramopoulos","year":"2015","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-018-1542-3","article-title":"Association of viral hepatitis and bipolar disorder: a nationwide population-based study","volume":"16","author":"Chong","year":"2018","journal-title":"J Transl Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1001\/jamapsychiatry.2019.2499","article-title":"Association of cytomegalovirus and toxoplasma gondii antibody titers with bipolar disorder","volume":"76","author":"Frye","year":"2019","journal-title":"JAMA Psychiat"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-018-1821-9","article-title":"Immunoglobulin sub-class distribution in bipolar disorder and schizophrenia: potential relationship with latent toxoplasma Gondii infection","volume":"18","author":"Hamdani","year":"2018","journal-title":"BMC Psychiatry"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e1116","DOI":"10.1002\/cti2.1116","article-title":"Hypothesis: bipolar disorder is an Epstein\u2013Barr virus-driven chronic autoimmune disease\u2013implications for immunotherapy","volume":"9","author":"Pender","year":"2020","journal-title":"Clin Translational Immunol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41380-021-01091-4","article-title":"A unified model of the pathophysiology of bipolar disorder","volume":"27","author":"Magioncalda","year":"2021","journal-title":"Mol Psychiatry"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.pbb.2018.12.006","article-title":"Revisiting inflammation in bipolar disorder","volume":"177","author":"Fries","year":"2019","journal-title":"Pharmacol Biochem Behav"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/bdi.12244","article-title":"An observational study of inflammation in the central nervous system in patients with bipolar disorder","volume":"17","author":"Stich","year":"2015","journal-title":"Bipolar Disord"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4088\/JCP.14r09007","article-title":"C-reactive protein alterations in bipolar disorder: a meta-analysis","volume":"76","author":"Darg\u00e9l","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-42482-6","article-title":"Peripheral blood lymphocyte subpopulations in patients with bipolar disorder type II","volume":"9","author":"Pietruczuk","year":"2019","journal-title":"Sci Rep"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/sj.jid.5700001","article-title":"Cytotoxic T cells","volume":"126","author":"Andersen","year":"2006","journal-title":"J Investig Dermatol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/pcn.12112","article-title":"Mental disorders that exacerbated due to the F ukushima disaster, a complex radioactive contamination disaster","volume":"68","author":"Matsumoto","year":"2014","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.dsx.2020.05.035","article-title":"Psychosocial impact of COVID-19","volume":"14","author":"Dubey","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.12688\/f1000research.24457.1","article-title":"Epidemiology of mental health problems in COVID-19: A review","volume":"9","author":"Hossain","year":"2020","journal-title":"F1000Res"},{"volume-title":"Mental Health and Psychosocial Considerations During the COVID-19 Outbreak","year":"2020","key":"ref48"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4088\/PCC.v03n0104","article-title":"Mood and cognitive changes during systemic corticosteroid therapy","volume":"3","author":"Brown","year":"2001","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.18502\/JIMC.V4I4.8486","article-title":"\u201cCovid-19 management\u201d induced mania! A call for alert and further research","author":"Hosseinnia","year":"2021","journal-title":"J Iranian Med Council"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1080\/08998280.2019.1629223","article-title":"Steroid-induced psychosis","volume":"32","author":"Janes","year":"2019","journal-title":"Baylor Univ Med Center Proc"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1102450\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T06:05:39Z","timestamp":1681193139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1102450\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":51,"alternative-id":["10.3389\/fpsyt.2023.1102450"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1102450","relation":{},"ISSN":["1664-0640"],"issn-type":[{"type":"electronic","value":"1664-0640"}],"subject":[],"published":{"date-parts":[[2023,4,11]]},"article-number":"1102450"}}